Y-BOCS (Yale-Brown Obsessive Compulsive Scale): Clinical Screening Tool for OCD Severity

The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is a clinician-administered rating instrument designed to measure the severity of obsessive-compulsive disorder (OCD) symptoms. Developed in the late 1980s by Wayne Goodman, MD, and colleagues at Yale University and Brown University, the Y-BOCS has become the most widely used outcome measure in OCD clinical research and treatment monitoring worldwide.

Unlike diagnostic tools that determine whether OCD is present, the Y-BOCS was specifically designed to quantify how severe obsessions and compulsions are — independent of the number or type of obsessive-compulsive symptoms a person experiences. This distinction is critical: two individuals can have very different obsessional content (e.g., contamination fears versus intrusive violent thoughts) yet receive comparable Y-BOCS scores if the symptoms affect their lives to a similar degree.

The instrument consists of two main components:

• A symptom checklist — a comprehensive inventory of common obsessions and compulsions used to identify which specific symptoms are present. This checklist is not scored but serves as a reference for the subsequent severity ratings.
• A 10-item severity scale — five items rating obsessions and five items rating compulsions across specific dimensions of severity, each scored from 0 to 4.

The Y-BOCS addresses a problem that plagued earlier OCD measurement tools: the tendency to conflate symptom content with severity. A person with a single, all-consuming obsession can be just as impaired as someone with multiple obsessions. The Y-BOCS captures this by focusing purely on the functional impact of symptoms rather than their variety or specific themes.

The Y-BOCS measures OCD severity across five parallel dimensions, applied separately to obsessions and compulsions. Each dimension is rated on a 0–4 scale, where 0 indicates no symptoms and 4 indicates extreme severity.

For obsessions, the five rated dimensions are:

• Time occupied by obsessions — How much of the person's day is consumed by intrusive obsessive thoughts? Ratings range from "none" (0) to "near-constant or extremely frequent" (4), with the midpoint (2) representing 1–3 hours per day.
• Interference from obsessions — To what extent do obsessions disrupt daily functioning, including work, social activities, and routine tasks?
• Distress associated with obsessions — How much anxiety, disturbance, or emotional suffering do the obsessions cause?
• Resistance against obsessions — How much effort does the person make to resist or dismiss obsessive thoughts? Notably, a higher resistance score indicates healthier functioning; complete capitulation to obsessions scores a 4.
• Control over obsessions — How successful is the person at dismissing or redirecting away from obsessive thoughts?

For compulsions, the five parallel dimensions are:

• Time spent on compulsions — How much time per day is devoted to compulsive behaviors or rituals?
• Interference from compulsions — How much do compulsive behaviors interfere with daily functioning?
• Distress associated with compulsions — How much anxiety or distress would the person experience if prevented from performing compulsions?
• Resistance against compulsions — How much effort is made to resist performing compulsive behaviors?
• Control over compulsions — How much control does the person have over compulsive behavior?

This multidimensional approach captures the complexity of OCD in ways that simple frequency counts or global severity ratings cannot. A person might spend relatively little time on compulsions but experience extreme distress when they resist them — the Y-BOCS captures both of these dimensions independently.

The Y-BOCS was developed for use with adults who have a confirmed or suspected diagnosis of OCD as defined by the DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision). The DSM-5-TR classifies OCD under "Obsessive-Compulsive and Related Disorders" and requires the presence of obsessions, compulsions, or both that are time-consuming (generally exceeding one hour per day), cause clinically significant distress, or impair social, occupational, or other important areas of functioning.

Notably, the Y-BOCS is not a diagnostic instrument. It does not determine whether someone has OCD. Rather, it presumes that a clinical diagnosis has been established (or is under evaluation) and measures the severity of the symptoms present. Clinicians typically conduct a diagnostic interview — often using the Structured Clinical Interview for DSM-5 (SCID-5) or the Mini International Neuropsychiatric Interview (MINI) — before administering the Y-BOCS.

Populations and adaptations:

• Adults — The original Y-BOCS was validated in adult populations, typically ages 18 and older.
• Children and adolescents — A modified version, the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS), was developed by Scahill and colleagues for use with younger populations. It uses simplified language and parent/child interview formats.
• Self-report versions — While the standard Y-BOCS is clinician-administered, self-report adaptations exist, including the Y-BOCS-SR (Self-Report). These are useful for screening and research but are generally considered less reliable than the clinician-administered version for clinical decision-making.
• Y-BOCS-II — A revised version published in 2010 by Storch and colleagues updated several items, modified the scoring anchors, and improved psychometric properties. The Y-BOCS-II uses a 0–5 scale per item (total range 0–50) and eliminated the resistance items, replacing them with obsession-free intervals and compulsion-free intervals.

The Y-BOCS is used across diverse clinical settings, including outpatient psychiatry clinics, specialized OCD treatment centers, inpatient units, and clinical research trials. It is the standard primary outcome measure in virtually all pharmacological and psychotherapy trials for OCD.

The Y-BOCS is a semi-structured, clinician-administered interview that typically takes 15 to 30 minutes to complete, depending on the complexity of the patient's symptoms and the clinician's experience with the instrument.

Step 1: Symptom Checklist

The clinician begins by reviewing the Y-BOCS Symptom Checklist with the patient. This checklist contains categories of common obsessions (aggressive, contamination, sexual, hoarding, religious, symmetry/exactness, somatic, and miscellaneous) and compulsions (cleaning/washing, checking, repeating, counting, ordering/arranging, hoarding/collecting, and miscellaneous). The clinician works through the checklist collaboratively, identifying which specific obsessions and compulsions the patient currently experiences. Target symptoms — usually the three most prominent obsessions and three most prominent compulsions — are identified for reference during the severity rating.

Step 2: Severity Ratings

The clinician then asks structured questions about each of the 10 severity dimensions. For each item, the clinician uses specific anchor points and probing questions provided in the Y-BOCS manual. For example, when rating "time occupied by obsessions," the clinician might ask: "How much of your time is occupied by obsessive thoughts? How frequently do they occur?" The clinician uses the patient's responses, along with clinical judgment, to assign a rating from 0 to 4.

Important administration considerations:

• The Y-BOCS should be administered by a trained clinician — typically a psychiatrist, psychologist, licensed clinical social worker, or trained research rater. Adequate training ensures consistent scoring and reduces rater variability.
• Ratings should reflect the patient's experience over the past week (or another specified time frame, consistently applied).
• The clinician should rate severity based on the composite of all obsessions taken together and all compulsions taken together, not on individual symptoms in isolation.
• Clinical judgment is essential — the clinician integrates the patient's self-report with behavioral observations and collateral information when available.

For repeated administrations (e.g., tracking treatment progress), consistency in rater and administration conditions is important to ensure that changes in scores reflect genuine clinical change rather than measurement variability.

The Y-BOCS generates several scores that clinicians use to assess OCD severity:

Total Score (0–40)

The total Y-BOCS score is the sum of all 10 severity items. Each item is scored 0–4, yielding a total possible range of 0 to 40. This total score is the primary measure of OCD severity and is the score most commonly reported in clinical research.

Widely used severity ranges for the total Y-BOCS score:

• 0–7: Subclinical — Minimal or no symptoms. Obsessions and compulsions, if present, cause negligible impairment.
• 8–15: Mild — Symptoms are present and noticeable but cause only limited interference with daily functioning. The individual generally maintains work, social, and daily routines.
• 16–23: Moderate — Symptoms cause significant distress and meaningful interference with functioning but are not completely disabling. Most individuals at this severity level are functioning with notable difficulty.
• 24–31: Severe — Symptoms cause substantial impairment. The individual struggles to maintain normal routines, and obsessions and compulsions consume large portions of the day.
• 32–40: Extreme — Symptoms are nearly incapacitating. Obsessions and compulsions dominate almost all waking hours, and independent functioning is severely compromised.

Obsession and Compulsion Subscores

The obsession subscore (items 1–5, range 0–20) and compulsion subscore (items 6–10, range 0–20) can be examined separately. This is clinically useful because some individuals present with predominantly obsessional symptoms (sometimes called "Pure O," though this terminology is debated clinically) or predominantly compulsive symptoms. The subscores help clinicians understand the relative contribution of each symptom domain to overall severity.

Clinically Significant Response to Treatment

In clinical trials, a treatment response is typically defined as a 35% or greater reduction in Y-BOCS total score from baseline, although some studies use a 25% threshold. Remission is generally defined as a total score of 12 or below, though some researchers use a cutoff of 14 or 16. These thresholds are important because they provide benchmarks for evaluating whether a given treatment — whether pharmacological, psychotherapeutic, or neuromodulatory — produces clinically meaningful change.

It is worth emphasizing that these severity categories are clinical conventions, not rigid diagnostic boundaries. A score of 16 and a score of 15 do not represent fundamentally different clinical states. Clinicians interpret Y-BOCS scores in the context of the full clinical picture, including the patient's subjective experience, functional impairment, and history.

The Y-BOCS is one of the most extensively validated instruments in psychiatric measurement. Its psychometric properties have been evaluated across numerous studies and clinical populations over more than three decades.

Reliability

• Internal consistency — The Y-BOCS demonstrates good to excellent internal consistency, with Cronbach's alpha values typically reported in the range of 0.80 to 0.91 across studies. This indicates that the items collectively measure a coherent construct.
• Inter-rater reliability — When different clinicians independently rate the same patient, agreement is generally high. Intraclass correlation coefficients (ICCs) typically exceed 0.90 for the total score, indicating that trained raters arrive at very similar severity assessments. This is critical for multi-site clinical trials where different raters at different locations need to produce comparable scores.
• Test-retest reliability — Scores remain stable over short intervals when the clinical condition has not changed, with test-retest correlation coefficients generally reported above 0.80.

Validity

• Convergent validity — Y-BOCS scores correlate significantly with other measures of OCD severity, including the NIMH Global Obsessive-Compulsive Scale and the Clinical Global Impression – Severity scale (CGI-S). Correlations with self-report OCD measures such as the Obsessive-Compulsive Inventory – Revised (OCI-R) are moderate to strong.
• Discriminant validity — The Y-BOCS is designed to measure OCD severity specifically and shows only modest correlations with general anxiety and depression measures. This is important because it means the Y-BOCS is capturing OCD-specific pathology rather than general psychological distress, though some overlap with depression scores is expected given the high comorbidity between OCD and depressive disorders.
• Sensitivity to change — The Y-BOCS is highly sensitive to clinical change over time, making it an excellent tool for tracking treatment progress. This property is the primary reason it has been adopted as the gold-standard outcome measure in OCD treatment trials.

Factor structure

Factor analytic studies have generally identified a two-factor structure corresponding to the obsession and compulsion subscales, though some studies suggest a three-factor solution that separates a "resistance/control" factor. The factor structure has been a topic of ongoing psychometric debate, and it was partly addressed in the Y-BOCS-II revision.

Despite its status as the gold standard, the Y-BOCS has recognized limitations that clinicians and researchers should understand.

Resistance items are problematic. The two resistance items (resistance to obsessions and resistance to compulsions) have consistently shown weaker psychometric properties than the other eight items. Research demonstrates that resistance can follow a non-linear pattern — early in treatment, patients may increase their resistance efforts, while in severe or chronic cases, patients may abandon resistance entirely. This creates scoring ambiguity. The Y-BOCS-II addressed this by replacing resistance items with "obsession-free interval" and "compulsion-free interval" items.

The instrument does not capture avoidance well. Many individuals with OCD engage in extensive avoidance behaviors — avoiding situations, places, or stimuli that trigger obsessions. Avoidance can be profoundly disabling, yet the Y-BOCS does not directly assess it. A person who avoids so thoroughly that obsessions rarely surface may receive a lower score than their functional impairment warrants.

Limited sensitivity at the extremes. The Y-BOCS may have ceiling effects in extremely severe cases and floor effects in mild cases, potentially underestimating change in patients at the most severe or mildest ends of the spectrum.

Clinician administration requires training and time. Proper Y-BOCS administration requires trained raters, making it more resource-intensive than self-report measures. In busy clinical settings, this can be a practical barrier. While self-report versions exist, they sacrifice some of the reliability advantages of the clinician-administered format.

Cultural and linguistic considerations. Although the Y-BOCS has been translated into many languages and used internationally, cultural differences in how OCD manifests — particularly the content and expression of obsessions related to religion, sexuality, or morality — can affect both the symptom checklist review and the severity ratings. Clinicians should remain attentive to culturally shaped symptom presentations.

Does not distinguish between OCD subtypes. The Y-BOCS provides a global severity score but does not differentiate between OCD subtypes (contamination, symmetry, forbidden thoughts, hoarding, etc.). Researchers studying subtype-specific treatment responses often need to supplement the Y-BOCS with additional measures. Notably, hoarding disorder is now classified as a separate diagnosis in the DSM-5-TR, and the Y-BOCS may not adequately capture hoarding-specific severity; the Saving Inventory – Revised (SI-R) is preferred for that purpose.

Insight is not well captured. The original Y-BOCS includes an investigational item on insight (awareness that obsessions/compulsions are excessive), but it is not included in the total severity score. Since the DSM-5-TR specifies insight levels as part of OCD diagnosis (good/fair, poor, and absent insight/delusional beliefs), this is a notable gap.

The Y-BOCS serves multiple functions across clinical and research settings:

Treatment planning and monitoring

Clinicians use the Y-BOCS at baseline to establish a severity benchmark and then re-administer it at regular intervals — typically every 2 to 4 weeks during active treatment — to track response. A consistent downward trajectory in Y-BOCS scores provides objective evidence that a treatment is working. On the other hand, stable or rising scores may prompt a clinician to adjust the treatment approach, whether that means modifying exposure and response prevention (ERP) protocols, adjusting medication doses, or considering augmentation strategies.

Clinical trial endpoints

The Y-BOCS total score is the primary outcome measure in the vast majority of OCD clinical trials. Regulatory agencies, including the U.S. Food and Drug Administration (FDA), expect Y-BOCS data in applications for OCD treatment indications. The standardized use of this single instrument across studies enables meta-analytic comparisons and evidence synthesis that would not be possible with heterogeneous outcome measures.

Treatment decision thresholds

While no rigid score-based algorithms dictate treatment choices, Y-BOCS severity categories inform general clinical decision-making:

• Mild OCD (8–15) — Cognitive-behavioral therapy (CBT) with ERP is typically recommended as first-line treatment. Some patients in this range may not require medication.
• Moderate OCD (16–23) — CBT with ERP remains first-line, often combined with a selective serotonin reuptake inhibitor (SSRI). Combination treatment is frequently considered at this severity level.
• Severe to extreme OCD (24–40) — More intensive interventions are often considered, including higher-dose SSRI treatment, SSRI augmentation with low-dose antipsychotics, intensive outpatient or residential treatment programs, and in treatment-refractory cases, neuromodulation approaches such as deep brain stimulation (DBS) or transcranial magnetic stimulation (TMS).

Communication tool

The Y-BOCS provides a shared language for clinicians, patients, and treatment teams. Telling a patient, "Your score has decreased from 28 to 18 over the past three months" gives them concrete, understandable feedback about their progress. It also facilitates communication across providers in multidisciplinary treatment settings.

Insurance and utilization review

In some healthcare systems, documented Y-BOCS scores support clinical justification for treatment intensity. For example, a score in the severe range may support the medical necessity of intensive outpatient treatment or residential care.

The original Y-BOCS instrument, including the symptom checklist and severity rating scale, is available in the published literature and is considered in the public domain. It can be accessed through several channels:

• Published source — The original Y-BOCS was published in: Goodman WK, Price LH, Rasmussen SA, et al. "The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability." Archives of General Psychiatry. 1989;46(11):1006–1011. The companion article on validity was published in the same journal volume.
• Clinical training resources — Many OCD specialty clinics and training programs provide the Y-BOCS along with administration guides and scoring instructions as part of clinical training materials.
• Research repositories — The instrument is freely available through various academic and clinical resource databases. The International OCD Foundation (IOCDF) provides educational resources about the Y-BOCS and related assessment tools.
• Y-BOCS-II — The revised version (Y-BOCS-II) may have different access requirements as it was published through specific academic channels. Clinicians should consult the original publication by Storch and colleagues (2010) for details.
• Self-report versions — Various self-report adaptations are available online, but clinicians should verify that any version used is a validated adaptation rather than an informal modification.

Important note: While the Y-BOCS instrument itself is accessible, proper administration requires clinical training. Online self-report versions encountered outside of clinical settings should be understood as informational tools, not substitutes for professional evaluation. If you are experiencing patterns consistent with OCD symptoms, the appropriate step is to seek evaluation from a qualified mental health professional — ideally one with specialized experience in OCD assessment and treatment.

If you experience persistent, unwanted intrusive thoughts, images, or urges that cause significant distress, or if you engage in repetitive behaviors or mental acts that feel driven and difficult to control, it is appropriate to seek evaluation from a mental health professional. These patterns may align with features of OCD or related conditions, and a trained clinician can conduct a comprehensive assessment.

Professional evaluation is especially important if:

• Obsessive thoughts or compulsive behaviors consume an hour or more per day
• Symptoms interfere with your ability to work, attend school, maintain relationships, or complete daily routines
• You are avoiding situations, places, or people because of fear-based obsessive thoughts
• You experience significant emotional distress related to intrusive thoughts or the need to perform rituals
• Symptoms have been present for weeks or months and are not improving on their own

OCD is one of the most treatable mental health conditions when evidence-based interventions are applied. CBT with exposure and response prevention has strong empirical support, and pharmacological options provide additional benefit for many individuals. Early intervention generally leads to better outcomes. A qualified clinician can use tools like the Y-BOCS to assess severity and guide treatment decisions tailored to your specific clinical picture.

You can find OCD-specialized therapists through the International OCD Foundation (IOCDF) provider directory, the Association for Behavioral and Cognitive Therapies (ABCT), or by asking a primary care provider for a referral to a mental health professional experienced in treating OCD.